Breaking AI & Tech News Analyzed

Korean culture is taking Latin America by storm, with K-pop, K-dramas, and Korean skincare products leading the charge. In Santiago, Chile, a group of young girls can be seen dancing to the beat of Blackpink's 'How You Like That', a song with over 1.3 billion views on YouTube. The phenomenon, known as hallyu or the 'Korean wave', has been spreading rapidly across the region, with Mexico, Colombia, and Brazil being key markets. Online personalities like Sujin Kim, known as Chingu Amiga, have become incredibly popular, sharing their love of K-dramas and skincare products with millions of followers. In Colombia, K-pop fan Zion Hwang has set up a string of karaoke restaurants to capitalize on the trend, while in Brazil, Korean-Brazilian influencers like Arthur Paek are promoting Korean culture and cuisine to their millions of followers. The Korean wave has also led to an increase in interest in Korean language and culture, with universities offering Korean studies programs and language classes becoming increasingly popular. Dr. Jinok Choi, director of the Universidad Central's Rey Sejong Institute in Santiago, notes that young Chileans are showing a 'real commitment to learning about Korea beyond just its culture'. The growth of Korean culture in Latin America is also being driven by a decline in the US's international appeal, with some observers suggesting that the US's flagging popularity under Donald Trump has led to a shift in interest towards Asian culture. Brazil's health minister, Alexandre Padilha, notes that 'perhaps the US is no longer, in people's imagination, the place they want to go'. As the Korean wave continues to sweep across Latin America, it's clear that Korean culture is here to stay. With K-pop concerts and K-drama fan events becoming increasingly popular, it's likely that the trend will only continue to grow in the coming years.

Irish MEP Barry Andrews toured makeshift shelters in Beirut last month, where displaced families are living on dirty mattresses and blankets and suffering from infections. The conditions, he said, are worse than during Israel’s 2024 incursion, underscoring the human cost of Israel’s retaliatory strikes after Hezbollah fired rockets into Israel.On returning to Dublin, Andrews became one of the first European lawmakers to urge the European Union to revive sanctions against Israel. He argued that the EU must also address state‑backed settler violence in the West Bank, attacks on health workers in Gaza, and Israel’s recent move to reinstate the death penalty for Palestinians convicted of terrorism.The EU’s leverage lies in its association agreement with Israel, a commerce and cooperation accord that underpins a €68 billion (€59 bn) trading relationship and includes cooperation on energy and scientific research. Former EU representative to the Palestinian territories, Sven Kühn von Burgsdorff, says the bloc should suspend this agreement, halt all military aid, and cease trade with illegal settlements, warning that inaction will further damage the EU’s reputation.Andrews described the EU’s reaction to the Iran‑Israel‑Lebanon war as “weak and pathetic,” adding that it effectively gives Israel a “permission slip for endless war crimes.” The European Commission condemned the Knesset’s death‑penalty vote as “very concerning” and a “clear step backwards,” while the Council of Europe called it a “legal anachronism” incompatible with modern human‑rights standards.Human‑rights figures note that in the past four weeks more than 1,240 people have been killed in Lebanon—including at least 124 children—and over 1.1 million have been displaced. In Gaza, the death toll has risen by 673 since the October ceasefire, bringing the total to 72,260 deaths.EU leaders have been divided on how to respond. Former Commission President Ursula von der Leyen proposed unprecedented sanctions last September, citing a “man‑made famine” in Gaza, but the proposal failed to secure a majority in the Council of Ministers, losing momentum after the U.S. announced a cease‑fire plan.Member states also differ: Ireland, Spain and Slovenia champion the Palestinian cause, whereas Germany, Austria and Hungary—led by Viktor Orbán, a close ally of Prime Minister Benjamin Netanyahu—have resisted measures such as sanctions on West Bank settlers.Despite these divisions, a senior EU diplomat warned in mid‑March that the bloc may need to “increase pressure on Israel again,” citing the “highly problematic” situation in Gaza and the West Bank. Another diplomat highlighted the importance of engaging with Israeli civil society, noting an open letter from 600 Israeli security officials urging an end to the Gaza war.In a recent statement, a Commission spokesperson reiterated that diplomatic engagement with Israel continues, describing it as the standard approach when partners “do not see developments eye to eye.” Yet former EU envoy Kühn von Burgsdorff cautioned that the EU cannot appear as a “sidekick” to an “erratic, unreliable” U.S. president or a “warmongering, annexationist” Israeli prime minister, as such a stance would undermine Europe’s global standing.

The United States has been proposing unusual bilateral health agreements to developing countries, mostly in Africa, in exchange for access to sensitive health data and critical minerals. These deals have sparked concerns of exploitation and have been met with resistance from several countries.In November, the US approached Zimbabwean authorities with a proposal that would have provided over $300m in funding in return for sensitive health data. However, Harare felt that the negotiations were 'lopsided' and promptly pulled out.Zambia also pushed back against a similar proposal, citing 'problematic' clauses that sought access to the country's minerals, including copper, cobalt, and lithium. The US had offered $1bn in funding over five years, but Lusaka requested a review of the proposal.Several African countries, including Nigeria and Kenya, have signed the health pacts, but the terms agreed remain unclear.Data or mineral demands in return for health aid are unprecedented in the history of US-Africa relations. Policy experts argue that tying crucial funding to sensitive national assets could have negative consequences for African nations and the US itself.'Supporting global health has clear benefits to the United States in terms of prevention of pandemics that can affect Americans too,' said Sarang Shidore, Africa director at the Quincy Institute for Responsible Statecraft. 'Linking such aid to payoffs in the extraction of critical minerals smacks of exploitative practices.'African nations have long relied on US funding to foot many of their health bills. In 2024, African countries received $5.4bn in US assistance, largely spent on humanitarian, health, and disaster needs.However, the US has argued that aid cuts suit its America First agenda, which prioritizes national interests. The stance has been met with criticism, with some economists arguing that aid is often ineffective and causes overreliance.Washington is now focused on government-to-government deals, which have typically required governments to take on an increasing share of their own health budgets in the next four to five years.Some analysts see this as a positive move to reduce overdependence on foreign funding and force governments to prioritize health spending in their budgets. However, the clauses that Washington is demanding to leverage its aid for data, rare earth elements, and other minerals have caused widespread outrage in some countries.In the case of Zambia, the US reportedly asked for access to the country's critical minerals in return for $1bn over five years. The US also asked for a one-way data-sharing agreement for 10 years.If Lusaka fails to ink a deal, US aid funding to the country will be discontinued, which could mean losing the remnants of funding Zambia still receives from the PEPFAR programme.

Seven civilians were killed in Israeli attacks on Beirut’s southern suburbs on April 1, according to Lebanon’s Ministry of Public Health. The strike on the Jnah district killed five people and injured 21, while a separate raid on the town of Khaldeh resulted in two deaths and three injuries.Israeli officials said the operation aimed to eliminate a senior Hezbollah commander, though the militant group has neither confirmed nor denied the target. Security sources described the Jnah strike as a targeted assassination of vehicles rather than an apartment block, noting that many cars were parked near a school sheltering displaced residents.Hezbollah, meanwhile, reported cross‑border attacks and “fierce clashes” with Israeli soldiers near the border town of Shamaa, roughly 5 km from the frontier. The group also claimed to have fired more than 40 rockets toward northern Israel and engaged Israeli troops in other sectors.Since the latest escalation, at least ten Israeli soldiers have been reported killed, and three UN peacekeepers from UNIFIL lost their lives in southern Lebanon, prompting an investigation.The humanitarian toll continues to rise: Lebanon’s Health Ministry cites a death count of over 1,200 and notes that more than one million people have been displaced by the conflict.In Jerusalem, far‑right ministers are urging Prime Minister Benjamin Netanyahu to annex southern Lebanon, while the prime minister has ordered the army to expand the ground invasion to fundamentally alter the security situation in Israel’s north.Israeli Defense Minister Israel Katz warned that homes in Lebanese border villages would be demolished and that the estimated 600,000 displaced residents would not be allowed to return until Israel deems the area secure, fueling fears of a prolonged occupation.Lebanese Prime Minister Nawaf Salam recently banned Hezbollah’s military activities and called on the national army to prevent attacks from Lebanese territory. However, the Iran‑aligned militia, which operates independently of the Lebanese government, has refused to disarm and insists on repelling Israeli advances.

Tiger Woods has withdrawn from the opportunity to lead the United States team as captain at the 2027 Ryder Cup. The PGA of America announced this decision after Woods announced he would be stepping away from golf to focus on his health and wellbeing. The 15-time major winner was the favourite to take on the role for the US at the Irish resort of Adare Manor. However, following a recent car accident and a DUI charge, Woods has decided to prioritize his health. Woods was involved in a car accident last week where he clipped a trailer and rolled his Land Rover. Police reported that he showed signs of impairment, and investigators found two white pills identified as hydrocodone during a search of his vehicle. A statement from the PGA of America read: “We commend Tiger for prioritising his long-term health and deeply respect the courage it takes to make such a personal decision.” The organization will share further updates regarding the Ryder Cup captaincy when appropriate. Woods has undergone numerous surgeries throughout his career, particularly to his leg and ankle, after suffering multiple injuries in a serious crash in 2021. He was granted permission by a Florida judge to leave the US to enter a comprehensive inpatient treatment facility as he faces misdemeanor driving under the influence charges. The Martin County court judge, Darren Steele, granted the motion to travel submitted by Woods’ attorney, citing the golf superstar’s need for an “intensive, highly individualized and medically integrated program” away from media and public scrutiny.

The U.S. Food and Drug Administration announced on Wednesday that it has granted expedited approval to Eli Lilly’s oral weight‑loss medication, orforglipron—marketed under the brand name Foundayo. This makes Foundayo the second GLP‑1 pill to reach U.S. consumers, following Novo Nordisk’s Wegovy tablet approved in December. Orforglipron works by mimicking a natural hormone that regulates appetite and satiety, offering a non‑injectable alternative to existing GLP‑1 injectables. David A. Ricks, Eli Lilly’s chair and CEO, highlighted that fewer than one in ten eligible patients are currently using GLP‑1 therapies, citing barriers such as cost, stigma, and perceived complexity. Unlike Wegovy, which must be taken on an empty stomach each morning, Foundayo can be taken anytime of day regardless of meals, simplifying dosing schedules. Patients will start on a low dose that is gradually increased to mitigate side‑effects. Pricing is projected at $149 per month for the initial dose, with higher‑strength formulations potentially reaching $349 monthly. While private‑insurance coverage remains uncertain, a Trump‑administration proposal could allow Medicare to cover certain patients as early as this summer, with copayments as low as $50 per month. Distribution will commence on Monday through LillyDirect’s direct‑to‑consumer channel, with broader availability in pharmacies and telehealth platforms expected shortly thereafter. The convenience of a once‑daily pill is anticipated to improve adherence, especially for individuals who avoid injectables due to needle aversion or rigid dosing requirements. The approval follows a fast‑track submission submitted only months ago, positioning Foundayo to enter the market roughly three months after Wegovy. This rapid rollout is set to intensify competition in the burgeoning GLP‑1 space, where new agents are continually emerging with claims of better efficacy and lower costs.

Palantir’s claim that opposition to its NHS contract is driven by ideology was rebuked by Chi Onwurah, the Labour MP who chairs Parliament’s science, innovation and technology select committee. Onwurah said it is appropriate for ministers to explore a break‑clause option in the deal, underscoring the seriousness of the concerns raised. Louis Mosley, Palantir’s UK executive vice‑chair, had urged the government not to succumb to “ideologically motivated campaigners” as officials weighed a way out of a £330 million contract to deliver the Federated Data Platform (FDP) for NHS England. Ministers have now asked for advice on triggering the contract’s break clause amid growing scrutiny of Palantir’s expanding role in the public sector. The FDP is an AI‑enabled platform designed to integrate disparate health information across the NHS. Palantir already holds contracts with the Ministry of Defence, several police forces and the UK’s financial watchdog, the FCA. Onwurah’s cross‑party committee is set to publish its report in the coming weeks, covering the digital reorganisation of government services and the role of AI after a series of hearings that included experts, NHS leaders and representatives from companies such as Palantir. She identified three core issues: the manner in which the contract was awarded, the handling of patient data and the resulting trust deficit within the NHS, and the involvement of Peter Mandelson through his firm Global Counsel. “These are not fringe ideological concerns,” Onwurah told the Guardian. “They relate to contract transparency, vendor lock‑in, value for money and data security – matters that should concern everyone pushing the NHS towards digital transformation.” She added that the NHS’s post‑COVID fatigue and austerity‑driven burnout make any additional trust‑related resentment a significant barrier to progress. Onwurah noted that Palantir secured the contract after providing services to the NHS at a nominal cost – a tactic often used by large tech firms to position themselves as the most attractive government supplier. “It is right for the government to explore all options, including breaking the contract, given ongoing concerns about FDP uptake while Palantir remains at the helm,” she said. Liberal Democrat MP Martin Wrigley, also on the committee, urged the government to commission a new consortium of UK‑based tech experts to build a home‑grown NHS platform. During a previous committee appearance, Mosley accused British doctors of placing “ideology over patient interest” after they challenged the data‑processing contract. Speaking to the Times, Mosley warned that removing Palantir could jeopardise patient care and stall solutions to the NHS’s biggest challenges, arguing that the campaign against the firm would do more harm than good.

America faces an unprecedented concentration of wealth: the richest 1% now control more assets than the bottom 93% of households, and a single individual, Elon Musk, with a net worth of $805 billion, holds more wealth than the lower‑half of the population combined.Recent tax policies have amplified this gap. In the year following the largest tax cut in U.S. history, 938 billionaires added $1.5 trillion to their fortunes, while President Trump and his family saw a modest increase of $4 billion. Four Wall Street giants—BlackRock, Vanguard, Fidelity and State Street—own stakes in more than 95 % of publicly traded companies, cementing corporate dominance across the economy.Political influence mirrors financial power: by the 2026 midterms, just 50 billionaires had poured over $433 million into campaign activities, shaping policy to protect their interests.Meanwhile, the average American worker is earning roughly $20 per week less than in 1973 after inflation adjustment, despite decades of productivity gains. The Rand Corporation estimates that $79 trillion has shifted from the bottom 90 % to the top 1 % over the past half‑century.Economic hardship is widespread: 60 % of households live paycheck to paycheck, nearly half of older workers lack retirement savings, and over 20 % of seniors survive on less than $15,000 annually. Health‑care insecurity affects 85 million Americans, with more than 500,000 filing for bankruptcy each year due to medical debt.At the heart of the problem is a tax code engineered by the affluent. Billionaires now pay lower effective rates than typical workers. For example, Musk’s tax rate sits below 3.3 % compared with an 8.4 % rate for a truck driver; Jeff Bezos paid under 1 % versus 8.7 % for a firefighter; Michael Bloomberg’s rate was 1.3 % against 13.3 % for a registered nurse; and Warren Buffett’s rate was a mere 0.1 % while a schoolteacher paid nearly 10 %.Corporate tax avoidance compounds the issue. After a $900 billion corporate tax break, major firms such as Tesla, SpaceX, Palantir, Ticketmaster and the parent of Taco Bell, Pizza Hut and KFC reported zero federal income tax despite generating over $17 billion in profit.Public sentiment is shifting. In California, voters favor a billionaire tax by a two‑to‑one margin, and in New York City, 62 % back a 2 % surtax on the ultra‑wealthy. Nationwide, more than six in ten Americans believe the wealthy and large corporations pay too little.In response, Senator Sanders introduced legislation to impose a 5 % wealth tax on the 938 billionaires whose combined net worth exceeds $8.2 trillion. Over a decade, the measure would generate roughly $4.4 trillion.The first‑year rollout would deliver a $3,000 direct payment to every household earning $150,000 or less—equating to $12,000 for a typical family of four. Additional provisions include constructing 7 million affordable housing units, expanding Medicare to cover dental, vision and hearing, providing universal childcare, raising the minimum teacher salary to $60,000, and guaranteeing Medicaid‑funded home health care for seniors and people with disabilities.Crucially, the plan would reverse recent health‑care cuts that stripped coverage from 15 million Americans, ensuring no additional loss of insurance.Even if the tax were applied retroactively, the impact on the ultra‑rich would be modest relative to their fortunes: Elon Musk would owe an extra $42 billion, Mark Zuckerberg an additional $11 billion, and Jeff Bezos another $11 billion—figures that would barely dent their net worths.As Justice Louis Brandeis warned in 1933, “We must make our choice. We may have democracy, or we may have wealth concentrated in the hands of a few, but we cannot have both.” Senator Sanders argues the choice is clear: a democratic economy that serves the many, not a plutocratic system that serves the 1 %.The wealthiest Americans must begin contributing their fair share.

The Iran war has triggered a massive energy shortfall in Asia, forcing governments to ramp up their use of coal, the dirtiest fossil fuel. Countries across the region, including South Korea, Thailand, the Philippines, India, and Bangladesh, are trying to compensate for a drop-off in imported energy, much of which comes from the Middle East.Climate experts have warned that the increased use of coal will have a devastating environmental impact, and that the energy crisis should be a wake-up call for governments to invest in renewables. The crisis has highlighted the importance of renewable energy for energy security in Asia.The global market has flipped within four weeks from a healthy supply surplus to a severe deficit, leading to price spikes and fuel shortages. Almost 30bn cubic meters of LNG has been removed from global supply chains, with over 80% of this loss affecting the Indo-Pacific region.Experts warn that it will take years to recover LNG supplies and that the crisis will have a lasting impact on the energy landscape in Asia. Governments are racing to overcome shortfalls, with some countries introducing measures to reduce energy consumption, such as four-day workweeks and remote work arrangements.